Skip to content

144Accepted May 17, 3:11 PM ET

Enliven Therapeutics, Inc. 144

ORBIMED CAPITAL LLC

Accepted (ET)

3:11 PM

May 17, 2024

Filed

May 17, 2024

Documents

1

Size

4.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.